US20190133667A1 - Action/Counteraction Superimposed Double Chamber Board Area Tissue Ablation Device - Google Patents

Action/Counteraction Superimposed Double Chamber Board Area Tissue Ablation Device Download PDF

Info

Publication number
US20190133667A1
US20190133667A1 US16/236,875 US201816236875A US2019133667A1 US 20190133667 A1 US20190133667 A1 US 20190133667A1 US 201816236875 A US201816236875 A US 201816236875A US 2019133667 A1 US2019133667 A1 US 2019133667A1
Authority
US
United States
Prior art keywords
compartment
ablation
energy
left atrium
posterior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/236,875
Inventor
Jason S. Sperling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corfigo Inc
Original Assignee
Corfigo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corfigo Inc filed Critical Corfigo Inc
Priority to US16/236,875 priority Critical patent/US20190133667A1/en
Publication of US20190133667A1 publication Critical patent/US20190133667A1/en
Assigned to CORFIGO, INC. reassignment CORFIGO, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SPERLING, JASON
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/04Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00023Cooling or heating of the probe or tissue immediately surrounding the probe with fluids closed, i.e. without wound contact by the fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00041Heating, e.g. defrosting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/0016Energy applicators arranged in a two- or three dimensional array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • A61B2018/00232Balloons having an irregular shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00797Temperature measured by multiple temperature sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/04Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
    • A61B2090/0463Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery against cooling or freezing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/04Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
    • A61B2090/0472Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery against ultrasound energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/04Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
    • A61B2090/0481Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery against EM radiation, e.g. microwave
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/04Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
    • A61B2090/049Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery against light, e.g. laser

Definitions

  • Ablation of living tissue has been used as a therapeutic intervention to cure or improve certain disease states. More specifically, ablation of cardiac tissue has been used to treat a variety of cardiac rhythm disturbances, including those originating in both the atria (upper chambers) and ventricles (lower chambers). Most of these techniques involve the utilization of an energy source (radiofrequency energy, cryothermy, microwave, ultrasound or laser) to destroy living tissue and render such tissue into a scar that is incapable of conducting electrical energy. Regarding atrial fibrillation specifically, most ablative strategies target the pulmonary vein orifices and their transitions to the left atrium, while others are meant to create linear scar lesions within and around the left and right atria themselves.
  • an energy source radiofrequency energy, cryothermy, microwave, ultrasound or laser
  • balloon cryoablation of the pulmonary vein orifices creates broad circular lesions by freezing the areas where a balloon is placed to occlude the pulmonary vein, ideally at its junction with the left atrium proper. All of these strategies aim to either encircle or “box-in” target areas, or focally interrupt areas considered to be important sources of atrial fibrillation (always with a major focus on the pulmonary veins).
  • the role of the posterior wall of the left atrium heart chamber has been recognized as significant in more “advanced” forms of atrial fibrillation, and its role in “sustaining” atrial fibrillation, possibly by becoming hyperconductive due to eccentric scar formation. It has been postulated that thorough ablation of both the pulmonary vein origins and the entire posterior wall of the left atrium would be a very effective strategy specifically for advanced forms of atrial fibrillation (including persistent cases), and methods to implement this strategy have been emerging, but the tools are somewhat limited.
  • the pulmonary vein transitions are the source of most of the irregular voltage that typically initiates atrial fibrillation, but in advanced cases, the posterior aspect (back wall) of the left atrium somehow sustains the process of atrial fibrillation, even if the pulmonary veins have been ablated to be electrically isolated from the left atrium.
  • catheter-based strategies that aim to treat the posterior wall from the inside of the atrium are much more risky procedures than usual because of potential damage to contiguous structures, such as the esophagus, that lie right behind the left atrium that can be injured by inappropriate energy delivery.
  • CFAE ablation complex fractionated atrial electrograms
  • the catheter treatment lesions burns or freezes
  • CFAE ablation complex fractionated atrial electrograms
  • a linear ablation device has been used that can ablate multiple small strips of the posterior left atrium from the outside (avoiding damage to contiguous organs like the airway and esophagus), but in a piece-meal fashion.
  • the approach has demonstrated good proof of principle for treating persistent forms of atrial fibrillation with a limited experience.
  • radiofrequency energy algorithms typically self-limit energy delivery with increasing impedance (resistance) of the target tissue, such as occurs with the presence of epicardial fat, which sometimes insulates the posterior left atrial surface and may significantly inhibit ablation. Further, reaching certain parts of the posterior left atrium requires a level of technical proficiency that may be difficult to reproducibly achieve.
  • Atrial fibrillation is a serious disease that affects one in four Americans over 40 at some point in their lifetime, a treatment that is efficacious/reproducible, less invasive, quick, and easy to learn and apply has dramatic appeal and could save the healthcare system billions of dollars.
  • One aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces.
  • the opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two overlying and separate compartments being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment.
  • Embodiments of the device may be configured so that the first compartment resorbs energy by cryothermy or freezing (e.g., shuttling and venting gas, such as nitrogen oxide (N 2 O) or Argon, or another suitable gas) and the second compartment emits energy or insulates against croythermy (for example, by either active warming with an energy source or by circulating and venting tepid or warm saline or other fluid) to prevent energy resorption below the first compartment, where energy resorption (ablation by freezing) would not be intended.
  • cryothermy or freezing e.g., shuttling and venting gas, such as nitrogen oxide (N 2 O) or Argon, or another suitable gas
  • croythermy for example, by either active warming with an energy source or by circulating and venting tepid or warm saline or other fluid
  • the first compartment may emit energy by radiofrequency, ultrasound, microwave, magnetism or laser.
  • the second compartment may then utilize a cooling mechanism, which could be accomplished with gas shuttling, such as N 2 O or Argon, or with continuous infusion of tepid or cool saline (or other) solution that is vented outside the chamber after circulation and absorption of excess energy.
  • gas shuttling such as N 2 O or Argon
  • continuous infusion of tepid or cool saline (or other) solution that is vented outside the chamber after circulation and absorption of excess energy.
  • At least one port may communicate with each of the two compartments individually.
  • the at least one port may be used for shuttling gas or liquid, or to power/control electrical components, such as radiofrequency, laser or ultrasound.
  • the surface of at least one compartment may be generally shaped like a quadrilateral with one corner displaced further away from the other three corners (usually the lower left corner as shown and described herein) compared with how the other three corners are located with respect to one another.
  • the compartments may be expandable from a smaller collapsed shape.
  • the device may be collapsible or expandable by a roll-up mechanism; the device can be unrolled or expanded by infusing gas or liquid into the compartments or by another mechanical method.
  • At least one of the compartments may have integrated temperature sensors. Surfaces of at least one of the compartments may be generally convex. Each surface may have a surface area of at least six cm 2 .
  • Another aspect of the disclosure is directed to a method for ablating a broad and generally large planar area of tissue while heating or cooling a surface opposite an ablation target area to prevent ablation of an opposite surface.
  • Embodiments of the method may be achieved by a non-linear ablation device having two opposing surfaces.
  • the opposing surfaces may be associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two overlying and separate compartments being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment.
  • Each surface may have a surface area of at least six cm 2 .
  • the first compartment may resorb energy by cryothermy or freezing and the second compartment may emit energy or insulate against croythermy.
  • Yet another aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces. Each surface has a surface area of at least six cm 2 .
  • the opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two overlying and separate compartments being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment.
  • the non-linear ablation device is expandable from a smaller initial, collapsed configuration.
  • Another aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces. Each surface has a surface area of at least six cm 2 .
  • the opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to resorb energy by cryothermy or freezing, and a second compartment of the two underlying and separate compartment being configured to emit energy to oppose the cryothermy of the first compartment.
  • a further aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces. Each surface has a surface area of at least six cm 2 .
  • the opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two underlying and separate compartment being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment.
  • the surface of the device is shaped like a quadrilateral with one corner displaced/elongated further away from the other three corners compared with the other three corners, which are located with respect to one another.
  • the displace/elongated corner may be the left lower corner, as shown and described herein.
  • Another aspect of the disclosure is directed to a device having a surface area with a drooping/elongated lower left corner, the surface area may comprise a more stepwise elongation towards the left lower corner of the device as shown and described herein.
  • This arrangement enables more rigid sub-components to be incorporated into the ablation compartment of the device, such as microwave or ultrasound cells or radiofrequency/energy coils of differing lengths.
  • a further aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces, each surface having a surface area of at least six cm 2 .
  • the opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to resorb energy by cryothermy or freezing, and a second compartment of the two underlying and separate compartments being configured to emit energy to oppose the cryothermy of the first compartment.
  • the non-linear device is expandable from a smaller initial, collapsed configuration.
  • the surface of at least one compartment is generally shaped like a quadrilateral with one corner displaced further away from the other three corners.
  • the device described overcomes technical limitations of current approaches of posterior left atrium surface ablation by ablating a large and appropriate sized area of the posterior left atrium that can overcome limitations of radiofrequency energy ablation, while protecting adjacent (unintended) areas from ablation injury by providing a size-matched simultaneous counter-action to the ablative energy source.
  • An important iteration is a device that is deployed from a smaller size, so as to be used for a minimally invasive procedure.
  • Other aspects of the disclosure that facilitate easier implementation are surface shapes that generally match those of the posterior left atrium, which has an eccentric shape that is like a rectangle with a drooping/extending left lower corner.
  • FIG. 1A shows a device in an deflated condition from its right side, the device including an upper ablation chamber that is superimposed over a lower (anti-ablation) chamber that may or may not be expandable;
  • FIG. 1B shows the device in an inflated condition
  • FIG. 2 shows a top view of a device shaped like a posterior left atrium, with a quadrilateral having smooth transitions in the corners, and a lower left corner being displaced away from the others;
  • FIGS. 3A-3C show a collapsed device that is rolled up from the left and right sides, transitioning to an opened configuration of the device
  • FIG. 4A-4C show a device with a stepwise increase in surface area moving from right to left, with increases occurring towards the left lower corner or pole of the device when viewed in plan, with the device iterations utilizing microwave or ultrasound cells or differing length radiofrequency coils.
  • a device for simultaneous ablation of a relatively large surface area of tissue whose shape can be in contact with much or all of the available surface area of the posterior (back) wall of the left atrium is disclosed herein.
  • the device can be polar, having a front surface and a back surface, with only one surface intended to be in contact with the posterior left atrium, and the other surface being opposite the posterior left atrium.
  • the device shape can be non-linear, and the front surface and the back surface can be flat or convex and exceed six cm 2 in surface area.
  • the shape of the posterior left atrium can be complex and eccentric, but generally can be considered to be similar to a quadrilateral with non-parallel sides and rounded edges, with a tapering and increasing inferior aspect moving from right to left.
  • a device that can thoroughly ablate the entire left atrium in ideally one ablation, or, for example, in less than four ablations, is shown and described.
  • the device can be ideally deployed using established minimally invasive approaches to the posterior left atrium, and in these cases would be expandable from a smaller collapsed initial configuration.
  • An energy source ideally can be one that overcomes epicardial fat-insulation limitations of radiofrequency ablation algorithms so that all of the posterior left atrium can be successfully and quickly ablated with minimal risk.
  • Adjunctive procedures such as cryoballoon ablation of the pulmonary veins, are added to complete the ablation procedure.
  • the device is expandable from a collapsed configuration into a relatively flat or convex bladder (compartment) or overlying set of bladders (compartments) that is/are delivered into the posterior pericardium (beneath the posterior left atrium) using video surgery or through a direct approach below the heart, and ablating a broad surface area of the posterior left atrium while protecting against underlying adjacent organ injury.
  • a relatively flat or convex bladder (compartment) or overlying set of bladders (compartments) that is/are delivered into the posterior pericardium (beneath the posterior left atrium) using video surgery or through a direct approach below the heart, and ablating a broad surface area of the posterior left atrium while protecting against underlying adjacent organ injury.
  • the energy source described herein is cryothermy, it is conceivable that alternate energy sources could be used as well, such as radiofrequency, microwave, magnetism, ultrasound or laser.
  • An important feature of the device is counteraction of the posterior left atrial cooling or heating either by insulation or with broad-area provision of opposing warming or cooling action in an opposing bladder (compartment) to protect adjacent tissues opposite to the posterior (back) wall of the left atrium.
  • the ablation surface or chamber may separate from an anti-ablation chamber by a septum, or, there may be two independent but superimposed chambers or bladders.
  • the device is delivered into position as a collapsed item that is expandable or inflatable by being filled with gas or liquid or by any other mechanism. When expanded, the device can achieve a square, rectangular, oval, circular, and trapezoidal or another shape.
  • a preferred iteration is a single device that is designed in the general shape of the posterior surface of the human left atrium, having a generally quadrilateral or rectangular shaped device with four corners or poles, and with one corner that is elongated and/or widened, with the surface area of the device generally being over six cm 2 in area.
  • the device is shaped like a quadrilateral with the left lower corner displaced further away from the other three corners compared with how the other three corners are located with respect to one another.
  • the ablation surface or chamber which will ultimately be placed in contact with the back wall of the left atrium, is activated, loaded or charged with an ablation capacity, as by freezing or heating, and the anti-ablation chamber (on the polar opposite side of the ablation chamber/surface, and generally of similar dimensions) is loaded or charged with a warming or cooling capacity or some other method of protecting structures adjacent from the posterior left atrium from injury.
  • the device may include two plastic (e.g., polyurethane) compartments or bladders, the ablation chamber being infused with a liquid or gas, such as nitric or nitrous oxide, argon or helium, to achieve sub-zero temperatures, while the anti-ablation chamber is infused with warmed gas or liquid solution, or by any means to emit heat or energy.
  • the anti-ablation portion can be a protective or insulating barrier and not require shuttling of gas or liquid.
  • One or both chambers may contain integrated thermometers to monitor dynamic and steady-state temperatures during the ablation process in order to achieve and maintain specified targets for completeness of ablation as well as protection from injury.
  • the device could generally work like a double-sided bladder that is placed behind the left atrium heart chamber.
  • One side of the bladder may be positioned in direct contact with the posterior (back) wall of the left atrium, while the other side of the device/bladder may be in contact with the posterior pericardial sac, but not with the left atrium or heart itself.
  • the anti-ablation part of the device protects structures on the other side of the pericardial sac in that area (esophagus, aorta, lung, airway, nerves, and diaphragm, for example).
  • an expandable device can then again be partially or completely collapsed again for retrieval.
  • FIG. 1A illustrates a device in a deflated condition having a body with two superimposed compartments 1 , 2 .
  • Each compartment 1 , 2 has a generally flat or convex surface area that may or may not be expandable.
  • the device is connected to an electrical line 10 connected to a controller 11 for controlling the operation of energy sources or for filling or releasing the compartments 1 , 2 with gas or liquid by ports 3 , 4 , among other things.
  • Ports 3 or 4 may be complex electrical controllers that actuate a microwave, ultrasound, laser or other mechanism that is embedded within a compartment that causes heating or cooling.
  • FIG. 1B illustrates the same device having an expanded ablation compartment 1 and an expanded anti-ablation compartment 2 .
  • the surface areas are convex in this shown embodiment.
  • the controller 11 can supply power to electrical energy sources or fluid or gas sources that are provided to the compartments 1 , 2 by ports 3 and 4 , which are dedicated to the ablation compartment and to the anti-ablation compartment, respectively.
  • the septum 5 is configured to have insulating properties.
  • the device is in the shape of a quadrilateral with smooth transitions in the corners, with the lower left corner being displaced away from the others, looking down upon ablation compartment 1 .
  • port 3 delivers and recycles gas or liquid in (or provides power to) chamber 1
  • port 4 uniquely accesses anti-ablation compartment 2 , which is positioned behind compartment 1 .
  • the shape of this device conforms to the general shape of the posterior wall of the left atrium, with margin 8 being superior (dome of the left atrium), margin 7 abutting the left-sided pulmonary veins posteriorly, margin 6 abutting the right sided pulmonary veins posteriorly, and margin 9 abutting the most inferior aspect of the posterior left atrium, near its junction with the anatomic structure known as the coronary sinus. It should be noted that the left lower corner is displaced away from the rest of the quadrilateral.
  • FIGS. 3A-3C show the body of the device in a collapsed configuration, rolled up onto itself from both the left and right sides.
  • the specific pattern of rolling allows for the anti-ablation compartment 2 to be on the bottom or external aspect of the rolled up device, while the ablation compartment 1 is on the internal aspect.
  • FIG. 3B shows a more complete view of the device, with ports 3 and 4 connected to the rolled up device at its trailing end, e.g., by margin 9 shown to be deployed in FIG. 2 .
  • FIG. 3C shows the device partially expanding or unfurling, with the anti-ablation compartment 2 being rolled out underneath of ablation compartment 1 , which is being exposed by the device unfurling.
  • the leading end of the device e.g., margin 8 , is advanced underneath the heart (not shown), where once unfurled, the ablation compartment 1 comes into direct contact with the posterior wall of the left atrium.
  • FIG. 4A in another embodiment, a device with a stepwise elongation towards a left lower corner or pole (when viewed from above) is shown, with different-sized electrical coils to produce heat.
  • FIG. 4B shows coupling of individual cells with a surface area shape that elongates moving from right to left, with the largest area being the left lower aspect; these cells may emit ultrasound, microwave, laser, or another energy source.
  • FIG. 4C shows a device similar to the device shown in FIG. 4B when viewed from its right side, with an ablating surface compartment 1 , and a separate and underlying component 2 to counteract ablation of compartment 1 , actuated or controlled via ports dedicated to each compartment.
  • the ablation compartment 1 is connected to a source 12 of nitrous oxide (or another gas/liquid) via port/line 3 .
  • the anti-ablation compartment 2 is connected to a source 13 of warm saline solution via port/line 4 .
  • the sources 12 , 13 may be electrical energy sources.
  • the controller 11 is configured to control the operation of the device in accordance to inputs provided by an operator of the device.
  • the device disclosed herein may embody different configurations.
  • the first compartment 1 is configured to resorb energy by cryothermy or freezing and the second compartment 2 is configured to emit energy or insulates against croythermy.
  • the first compartment 1 is configured to emit energy by radiofrequency, ultrasound, microwave, magnetism or laser and the second compartment 2 is configured to utilize a cooling mechanism.
  • At least one port 3 or 4 communicates with each of the two compartments individually. In another embodiment, at least one port 3 or 4 is used for shuttling gas or liquid.
  • At least one of the compartments 1 or 2 has integrated temperature sensors, each indicated at 14 , to measure or otherwise detect temperature in the compartment.
  • both compartments 1 , 2 have integrated temperature sensors.
  • the sensors 14 are coupled to the controller, e.g., by line 10 , to provide information to the controller 11 . Based on the feedback from the sensors 14 , the controller 11 and/or an operator of the controller can manipulate the flow of material/energy from sources 12 , 13 via ports/lines 3 , 4 , respectively.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Physics & Mathematics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pathology (AREA)
  • Electromagnetism (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Plasma & Fusion (AREA)
  • Surgical Instruments (AREA)
  • Laser Surgery Devices (AREA)

Abstract

A non-linear ablation device includes two opposing surfaces, which are associated with two overlying and separate compartments. A first compartment of the two overlying and separate compartments is configured to emit or resorb energy. A second compartment of the two overlying and separate compartments is configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment. Other embodiments of the non-linear ablation device are further disclosed.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims priority as a continuation to U.S. application Ser. No. 14/772,654, filed on Sep. 3, 2015 and entitled “Action/Counteraction Superimposed Double Chamber Broad Area Tissue Ablation Device,” which claims the benefit under 35 U.S.C. § 371 to International PCT Patent Application PCT/US14/67143, filed on Nov. 24, 2014, which claims priority to U.S. Provisional Patent Application 61/909,218, filed Nov. 26, 2013 and entitled “Action/Counteraction Superimposed Double Chamber Broad Area Tissue Ablation Device,” all of which are hereby incorporated herein by reference in their entireties.
  • BACKGROUND OF THE DISCLOSURE
  • Ablation of living tissue has been used as a therapeutic intervention to cure or improve certain disease states. More specifically, ablation of cardiac tissue has been used to treat a variety of cardiac rhythm disturbances, including those originating in both the atria (upper chambers) and ventricles (lower chambers). Most of these techniques involve the utilization of an energy source (radiofrequency energy, cryothermy, microwave, ultrasound or laser) to destroy living tissue and render such tissue into a scar that is incapable of conducting electrical energy. Regarding atrial fibrillation specifically, most ablative strategies target the pulmonary vein orifices and their transitions to the left atrium, while others are meant to create linear scar lesions within and around the left and right atria themselves. In another technique, balloon cryoablation of the pulmonary vein orifices, creates broad circular lesions by freezing the areas where a balloon is placed to occlude the pulmonary vein, ideally at its junction with the left atrium proper. All of these strategies aim to either encircle or “box-in” target areas, or focally interrupt areas considered to be important sources of atrial fibrillation (always with a major focus on the pulmonary veins).
  • More recently, the role of the posterior wall of the left atrium heart chamber has been recognized as significant in more “advanced” forms of atrial fibrillation, and its role in “sustaining” atrial fibrillation, possibly by becoming hyperconductive due to eccentric scar formation. It has been postulated that thorough ablation of both the pulmonary vein origins and the entire posterior wall of the left atrium would be a very effective strategy specifically for advanced forms of atrial fibrillation (including persistent cases), and methods to implement this strategy have been emerging, but the tools are somewhat limited. While pulmonary vein ablation strategies work well in patients with smaller left atrium heart chambers and those who have earlier stage atrial fibrillation (paroxysmal or intermittent), many patients have more persistent forms of atrial fibrillation that cannot be treated successfully with pulmonary vein ablation (or “isolation”) alone. There have been attempts to ablate the posterior wall of the left atrium from “within” the left atrium, but in order to be effective, many lesions need to be delivered, each with a small but finite risk of other organ injury, including the airway and the esophagus.
  • Older surgical strategies (cut-and-sew Maze procedure) have shown reproducible success in these advanced cases, but the surgeries can be risky (require use of the heart-lung machine and cardiac arrest). Attempts to reproduce the extensive surgical lesions using minimally invasive techniques or less invasive tools (compared with “cut and sew”) showed some promise, but success rates have been modest and the “minimally invasive” nature has still been considered by most to be substantially invasive.
  • Among atrial fibrillation experts, it has been widely agreed that anatomically, the pulmonary vein transitions are the source of most of the irregular voltage that typically initiates atrial fibrillation, but in advanced cases, the posterior aspect (back wall) of the left atrium somehow sustains the process of atrial fibrillation, even if the pulmonary veins have been ablated to be electrically isolated from the left atrium. Unfortunately, catheter-based strategies that aim to treat the posterior wall from the inside of the atrium are much more risky procedures than usual because of potential damage to contiguous structures, such as the esophagus, that lie right behind the left atrium that can be injured by inappropriate energy delivery. Further, the results with catheter treatment (called CFAE ablation: complex fractionated atrial electrograms) vary dramatically because the catheter treatment lesions (burns or freezes) are far too small (like point- or spot-welding) to effectively treat (ablate) large and contiguous areas of posterior left atrial tissue. More recently, a linear ablation device has been used that can ablate multiple small strips of the posterior left atrium from the outside (avoiding damage to contiguous organs like the airway and esophagus), but in a piece-meal fashion. The approach has demonstrated good proof of principle for treating persistent forms of atrial fibrillation with a limited experience. The method seems to be more effective than “within-the-left atrium” approaches (catheter ablation), but is tedious to use, as it was intended as a device that creates roughly 3 cm×0.5 cm linear lesions to mimic aspects of the cut-and-sew Maze procedure, but is an imperfect device and method to treat the entire posterior left atrium as it comprises a much larger surface. Another important limitation is that radiofrequency energy algorithms typically self-limit energy delivery with increasing impedance (resistance) of the target tissue, such as occurs with the presence of epicardial fat, which sometimes insulates the posterior left atrial surface and may significantly inhibit ablation. Further, reaching certain parts of the posterior left atrium requires a level of technical proficiency that may be difficult to reproducibly achieve. Since atrial fibrillation is a serious disease that affects one in four Americans over 40 at some point in their lifetime, a treatment that is efficacious/reproducible, less invasive, quick, and easy to learn and apply has dramatic appeal and could save the healthcare system billions of dollars.
  • SUMMARY OF THE DISCLOSURE
  • One aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces. The opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two overlying and separate compartments being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment.
  • Embodiments of the device may be configured so that the first compartment resorbs energy by cryothermy or freezing (e.g., shuttling and venting gas, such as nitrogen oxide (N2O) or Argon, or another suitable gas) and the second compartment emits energy or insulates against croythermy (for example, by either active warming with an energy source or by circulating and venting tepid or warm saline or other fluid) to prevent energy resorption below the first compartment, where energy resorption (ablation by freezing) would not be intended.
  • The first compartment may emit energy by radiofrequency, ultrasound, microwave, magnetism or laser. The second compartment may then utilize a cooling mechanism, which could be accomplished with gas shuttling, such as N2O or Argon, or with continuous infusion of tepid or cool saline (or other) solution that is vented outside the chamber after circulation and absorption of excess energy.
  • At least one port may communicate with each of the two compartments individually. The at least one port may be used for shuttling gas or liquid, or to power/control electrical components, such as radiofrequency, laser or ultrasound.
  • The surface of at least one compartment may be generally shaped like a quadrilateral with one corner displaced further away from the other three corners (usually the lower left corner as shown and described herein) compared with how the other three corners are located with respect to one another.
  • The compartments may be expandable from a smaller collapsed shape. The device may be collapsible or expandable by a roll-up mechanism; the device can be unrolled or expanded by infusing gas or liquid into the compartments or by another mechanical method. At least one of the compartments may have integrated temperature sensors. Surfaces of at least one of the compartments may be generally convex. Each surface may have a surface area of at least six cm2.
  • Another aspect of the disclosure is directed to a method for ablating a broad and generally large planar area of tissue while heating or cooling a surface opposite an ablation target area to prevent ablation of an opposite surface.
  • Embodiments of the method may be achieved by a non-linear ablation device having two opposing surfaces. The opposing surfaces may be associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two overlying and separate compartments being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment. Each surface may have a surface area of at least six cm2. The first compartment may resorb energy by cryothermy or freezing and the second compartment may emit energy or insulate against croythermy.
  • Yet another aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces. Each surface has a surface area of at least six cm2. The opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two overlying and separate compartments being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment. The non-linear ablation device is expandable from a smaller initial, collapsed configuration.
  • Another aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces. Each surface has a surface area of at least six cm2. The opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to resorb energy by cryothermy or freezing, and a second compartment of the two underlying and separate compartment being configured to emit energy to oppose the cryothermy of the first compartment.
  • A further aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces. Each surface has a surface area of at least six cm2. The opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two underlying and separate compartment being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment. The surface of the device is shaped like a quadrilateral with one corner displaced/elongated further away from the other three corners compared with the other three corners, which are located with respect to one another. The displace/elongated corner may be the left lower corner, as shown and described herein.
  • Another aspect of the disclosure is directed to a device having a surface area with a drooping/elongated lower left corner, the surface area may comprise a more stepwise elongation towards the left lower corner of the device as shown and described herein. This arrangement enables more rigid sub-components to be incorporated into the ablation compartment of the device, such as microwave or ultrasound cells or radiofrequency/energy coils of differing lengths.
  • A further aspect of the disclosure is directed to a non-linear ablation device comprising two opposing surfaces, each surface having a surface area of at least six cm2. The opposing surfaces are associated with two overlying and separate compartments, with a first compartment of the two overlying and separate compartments being configured to resorb energy by cryothermy or freezing, and a second compartment of the two underlying and separate compartments being configured to emit energy to oppose the cryothermy of the first compartment. The non-linear device is expandable from a smaller initial, collapsed configuration. The surface of at least one compartment is generally shaped like a quadrilateral with one corner displaced further away from the other three corners.
  • The device described overcomes technical limitations of current approaches of posterior left atrium surface ablation by ablating a large and appropriate sized area of the posterior left atrium that can overcome limitations of radiofrequency energy ablation, while protecting adjacent (unintended) areas from ablation injury by providing a size-matched simultaneous counter-action to the ablative energy source. An important iteration is a device that is deployed from a smaller size, so as to be used for a minimally invasive procedure. Other aspects of the disclosure that facilitate easier implementation are surface shapes that generally match those of the posterior left atrium, which has an eccentric shape that is like a rectangle with a drooping/extending left lower corner.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings are not intended to be drawn to scale. In the drawings, each identical or nearly identical component that is illustrated in various figures is represented by a like numeral. For purposes of clarity, not every component may be labeled in every drawing. In the drawings:
  • FIG. 1A shows a device in an deflated condition from its right side, the device including an upper ablation chamber that is superimposed over a lower (anti-ablation) chamber that may or may not be expandable;
  • FIG. 1B shows the device in an inflated condition;
  • FIG. 2 shows a top view of a device shaped like a posterior left atrium, with a quadrilateral having smooth transitions in the corners, and a lower left corner being displaced away from the others;
  • FIGS. 3A-3C show a collapsed device that is rolled up from the left and right sides, transitioning to an opened configuration of the device; and
  • FIG. 4A-4C show a device with a stepwise increase in surface area moving from right to left, with increases occurring towards the left lower corner or pole of the device when viewed in plan, with the device iterations utilizing microwave or ultrasound cells or differing length radiofrequency coils.
  • DETAILED DESCRIPTION
  • A device for simultaneous ablation of a relatively large surface area of tissue whose shape can be in contact with much or all of the available surface area of the posterior (back) wall of the left atrium is disclosed herein. The device can be polar, having a front surface and a back surface, with only one surface intended to be in contact with the posterior left atrium, and the other surface being opposite the posterior left atrium. Generally, the device shape can be non-linear, and the front surface and the back surface can be flat or convex and exceed six cm2 in surface area. The shape of the posterior left atrium can be complex and eccentric, but generally can be considered to be similar to a quadrilateral with non-parallel sides and rounded edges, with a tapering and increasing inferior aspect moving from right to left.
  • In one embodiment, a device that can thoroughly ablate the entire left atrium in ideally one ablation, or, for example, in less than four ablations, is shown and described. In addition, the device can be ideally deployed using established minimally invasive approaches to the posterior left atrium, and in these cases would be expandable from a smaller collapsed initial configuration. An energy source ideally can be one that overcomes epicardial fat-insulation limitations of radiofrequency ablation algorithms so that all of the posterior left atrium can be successfully and quickly ablated with minimal risk. Adjunctive procedures, such as cryoballoon ablation of the pulmonary veins, are added to complete the ablation procedure.
  • In a major iteration, the device is expandable from a collapsed configuration into a relatively flat or convex bladder (compartment) or overlying set of bladders (compartments) that is/are delivered into the posterior pericardium (beneath the posterior left atrium) using video surgery or through a direct approach below the heart, and ablating a broad surface area of the posterior left atrium while protecting against underlying adjacent organ injury. While the energy source described herein is cryothermy, it is conceivable that alternate energy sources could be used as well, such as radiofrequency, microwave, magnetism, ultrasound or laser. An important feature of the device is counteraction of the posterior left atrial cooling or heating either by insulation or with broad-area provision of opposing warming or cooling action in an opposing bladder (compartment) to protect adjacent tissues opposite to the posterior (back) wall of the left atrium. The ablation surface or chamber may separate from an anti-ablation chamber by a septum, or, there may be two independent but superimposed chambers or bladders.
  • In one embodiment, the device is delivered into position as a collapsed item that is expandable or inflatable by being filled with gas or liquid or by any other mechanism. When expanded, the device can achieve a square, rectangular, oval, circular, and trapezoidal or another shape. A preferred iteration is a single device that is designed in the general shape of the posterior surface of the human left atrium, having a generally quadrilateral or rectangular shaped device with four corners or poles, and with one corner that is elongated and/or widened, with the surface area of the device generally being over six cm2 in area. In one embodiment, the device is shaped like a quadrilateral with the left lower corner displaced further away from the other three corners compared with how the other three corners are located with respect to one another. The ablation surface or chamber, which will ultimately be placed in contact with the back wall of the left atrium, is activated, loaded or charged with an ablation capacity, as by freezing or heating, and the anti-ablation chamber (on the polar opposite side of the ablation chamber/surface, and generally of similar dimensions) is loaded or charged with a warming or cooling capacity or some other method of protecting structures adjacent from the posterior left atrium from injury.
  • The device may include two plastic (e.g., polyurethane) compartments or bladders, the ablation chamber being infused with a liquid or gas, such as nitric or nitrous oxide, argon or helium, to achieve sub-zero temperatures, while the anti-ablation chamber is infused with warmed gas or liquid solution, or by any means to emit heat or energy. The anti-ablation portion can be a protective or insulating barrier and not require shuttling of gas or liquid. One or both chambers may contain integrated thermometers to monitor dynamic and steady-state temperatures during the ablation process in order to achieve and maintain specified targets for completeness of ablation as well as protection from injury. The device could generally work like a double-sided bladder that is placed behind the left atrium heart chamber. One side of the bladder may be positioned in direct contact with the posterior (back) wall of the left atrium, while the other side of the device/bladder may be in contact with the posterior pericardial sac, but not with the left atrium or heart itself. The anti-ablation part of the device protects structures on the other side of the pericardial sac in that area (esophagus, aorta, lung, airway, nerves, and diaphragm, for example). After the ablation sequence is completed, an expandable device can then again be partially or completely collapsed again for retrieval.
  • Referring to the drawings, FIG. 1A illustrates a device in a deflated condition having a body with two superimposed compartments 1, 2. Each compartment 1, 2 has a generally flat or convex surface area that may or may not be expandable. In a certain embodiment, the device is connected to an electrical line 10 connected to a controller 11 for controlling the operation of energy sources or for filling or releasing the compartments 1, 2 with gas or liquid by ports 3, 4, among other things. Ports 3 or 4 may be complex electrical controllers that actuate a microwave, ultrasound, laser or other mechanism that is embedded within a compartment that causes heating or cooling. FIG. 1B illustrates the same device having an expanded ablation compartment 1 and an expanded anti-ablation compartment 2. The surface areas are convex in this shown embodiment. The controller 11 can supply power to electrical energy sources or fluid or gas sources that are provided to the compartments 1, 2 by ports 3 and 4, which are dedicated to the ablation compartment and to the anti-ablation compartment, respectively. In one embodiment, there may be a shared septum 5 that separates ablation compartment 1 from anti-ablation compartment 2. The septum 5 is configured to have insulating properties.
  • Referring to FIG. 2, the device is in the shape of a quadrilateral with smooth transitions in the corners, with the lower left corner being displaced away from the others, looking down upon ablation compartment 1. As shown, port 3 delivers and recycles gas or liquid in (or provides power to) chamber 1, while port 4 uniquely accesses anti-ablation compartment 2, which is positioned behind compartment 1. The shape of this device conforms to the general shape of the posterior wall of the left atrium, with margin 8 being superior (dome of the left atrium), margin 7 abutting the left-sided pulmonary veins posteriorly, margin 6 abutting the right sided pulmonary veins posteriorly, and margin 9 abutting the most inferior aspect of the posterior left atrium, near its junction with the anatomic structure known as the coronary sinus. It should be noted that the left lower corner is displaced away from the rest of the quadrilateral.
  • Referring to FIGS. 3A-3C, FIGS. 3A and 3B show the body of the device in a collapsed configuration, rolled up onto itself from both the left and right sides. In this example, the specific pattern of rolling allows for the anti-ablation compartment 2 to be on the bottom or external aspect of the rolled up device, while the ablation compartment 1 is on the internal aspect. FIG. 3B shows a more complete view of the device, with ports 3 and 4 connected to the rolled up device at its trailing end, e.g., by margin 9 shown to be deployed in FIG. 2. FIG. 3C shows the device partially expanding or unfurling, with the anti-ablation compartment 2 being rolled out underneath of ablation compartment 1, which is being exposed by the device unfurling. The leading end of the device, e.g., margin 8, is advanced underneath the heart (not shown), where once unfurled, the ablation compartment 1 comes into direct contact with the posterior wall of the left atrium.
  • Referring to FIG. 4A, in another embodiment, a device with a stepwise elongation towards a left lower corner or pole (when viewed from above) is shown, with different-sized electrical coils to produce heat. Similarly FIG. 4B shows coupling of individual cells with a surface area shape that elongates moving from right to left, with the largest area being the left lower aspect; these cells may emit ultrasound, microwave, laser, or another energy source. FIG. 4C shows a device similar to the device shown in FIG. 4B when viewed from its right side, with an ablating surface compartment 1, and a separate and underlying component 2 to counteract ablation of compartment 1, actuated or controlled via ports dedicated to each compartment.
  • Referring back to FIGS. 1A and 1B, in one embodiment, the ablation compartment 1 is connected to a source 12 of nitrous oxide (or another gas/liquid) via port/line 3. The anti-ablation compartment 2 is connected to a source 13 of warm saline solution via port/line 4. In other embodiments, the sources 12, 13 may be electrical energy sources. As mentioned above, the controller 11 is configured to control the operation of the device in accordance to inputs provided by an operator of the device.
  • The device disclosed herein may embody different configurations. In one embodiment, the first compartment 1 is configured to resorb energy by cryothermy or freezing and the second compartment 2 is configured to emit energy or insulates against croythermy.
  • In another embodiment, the first compartment 1 is configured to emit energy by radiofrequency, ultrasound, microwave, magnetism or laser and the second compartment 2 is configured to utilize a cooling mechanism.
  • In certain embodiments, at least one port 3 or 4 communicates with each of the two compartments individually. In another embodiment, at least one port 3 or 4 is used for shuttling gas or liquid.
  • In one embodiment, with reference to FIGS. 1A and 1B, at least one of the compartments 1 or 2 has integrated temperature sensors, each indicated at 14, to measure or otherwise detect temperature in the compartment. In other embodiments, both compartments 1, 2 have integrated temperature sensors. The sensors 14 are coupled to the controller, e.g., by line 10, to provide information to the controller 11. Based on the feedback from the sensors 14, the controller 11 and/or an operator of the controller can manipulate the flow of material/energy from sources 12, 13 via ports/lines 3, 4, respectively.
  • This disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The principles set forth in this disclosure are capable of being provided in other embodiments and of being practiced or of being carried out in various ways. Also, the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” “having,” “containing,” “involving,” and variations thereof herein, is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.
  • Having thus described several aspects of at least one embodiment of this disclosure, it is to be appreciated various alterations, modifications, and improvements will readily occur to those skilled in the art. Such alterations, modifications, and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the disclosure. Accordingly, the foregoing description and drawings are by way of example only.

Claims (1)

What is claimed is:
1. A non-linear ablation device comprising two opposing surfaces, the opposing surfaces being associated with two overlying and separate compartments, a first compartment of the two overlying and separate compartments being configured to emit or resorb energy, and a second compartment of the two overlying and separate compartments being configured to either resorb or emit energy to oppose a direction of energy transfer of the first compartment.
US16/236,875 2013-11-26 2018-12-31 Action/Counteraction Superimposed Double Chamber Board Area Tissue Ablation Device Abandoned US20190133667A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/236,875 US20190133667A1 (en) 2013-11-26 2018-12-31 Action/Counteraction Superimposed Double Chamber Board Area Tissue Ablation Device

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361909218P 2013-11-26 2013-11-26
PCT/US2014/067143 WO2015081019A2 (en) 2013-11-26 2014-11-24 Action/counteraction superimposed double chamber, broad area tissue ablation device
US201514772654A 2015-09-03 2015-09-03
US16/236,875 US20190133667A1 (en) 2013-11-26 2018-12-31 Action/Counteraction Superimposed Double Chamber Board Area Tissue Ablation Device

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US14/772,654 Continuation US10166058B2 (en) 2013-11-26 2014-11-24 Action/counteraction superimposed double chamber broad area tissue ablation device
PCT/US2014/067143 Continuation WO2015081019A2 (en) 2013-11-26 2014-11-24 Action/counteraction superimposed double chamber, broad area tissue ablation device

Publications (1)

Publication Number Publication Date
US20190133667A1 true US20190133667A1 (en) 2019-05-09

Family

ID=53199717

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/772,654 Active US10166058B2 (en) 2013-11-26 2014-11-24 Action/counteraction superimposed double chamber broad area tissue ablation device
US16/236,875 Abandoned US20190133667A1 (en) 2013-11-26 2018-12-31 Action/Counteraction Superimposed Double Chamber Board Area Tissue Ablation Device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US14/772,654 Active US10166058B2 (en) 2013-11-26 2014-11-24 Action/counteraction superimposed double chamber broad area tissue ablation device

Country Status (10)

Country Link
US (2) US10166058B2 (en)
EP (1) EP3073931B1 (en)
JP (2) JP6154073B2 (en)
KR (1) KR101827290B1 (en)
CN (1) CN105813576B (en)
AU (1) AU2014354940B2 (en)
CA (1) CA2931484C (en)
ES (1) ES2793936T3 (en)
IL (2) IL245779B (en)
WO (1) WO2015081019A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106580425B (en) * 2016-11-28 2019-08-02 攀枝花市九鼎智远知识产权运营有限公司 A kind of liquid nitrogen frozen knife with hot warm cutting function
EP3570768A4 (en) * 2017-01-17 2020-10-21 Corfigo, Inc. Device for ablation of tissue surfaces and related systems and methods
US20190159835A1 (en) * 2017-11-29 2019-05-30 Atricure, Inc. Cryopad
US11690663B1 (en) * 2022-11-03 2023-07-04 Focused Cryo, Inc. Directional cryoablation system

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090182317A1 (en) * 2008-01-11 2009-07-16 Bencini Robert F Ablation devices and methods of use

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1001890C2 (en) 1995-12-13 1997-06-17 Cordis Europ Catheter with plate-shaped electrode array.
EP1063951B1 (en) * 1998-03-17 2009-09-16 Gary S. Kochamba Apparatus for stabilizing tissue
US7001378B2 (en) 1998-03-31 2006-02-21 Innercool Therapies, Inc. Method and device for performing cooling or cryo-therapies, for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection
US7097641B1 (en) 1999-12-09 2006-08-29 Cryocath Technologies Inc. Catheter with cryogenic and heating ablation
US20040006379A1 (en) * 2000-10-06 2004-01-08 Expanding Concepts, L.L.C. Epidural thermal posterior annuloplasty
US6932771B2 (en) * 2001-07-09 2005-08-23 Civco Medical Instruments Co., Inc. Tissue warming device and method
US20030153905A1 (en) * 2002-01-25 2003-08-14 Edwards Stuart Denzil Selective ablation system
US6858025B2 (en) * 2002-08-06 2005-02-22 Medically Advanced Designs, Llc Cryo-surgical apparatus and method of use
US7179254B2 (en) * 2004-03-09 2007-02-20 Ethicon, Inc. High intensity ablation device
US9555223B2 (en) * 2004-03-23 2017-01-31 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US7803150B2 (en) * 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US20100168567A1 (en) * 2005-12-15 2010-07-01 Galil Medical Ltd. Apparatus for Protecting a Cavity Wall During Ablation of Tissue Near the Cavity
US20070287994A1 (en) * 2006-06-12 2007-12-13 Pankaj Amrit Patel Endoscopically Introducible Expandable Bipolar Probe
US20080077126A1 (en) * 2006-09-22 2008-03-27 Rassoll Rashidi Ablation for atrial fibrillation
US9603674B2 (en) * 2008-05-30 2017-03-28 The Regents Of The University Of California Method to protect the esophagus and other mediastinal structures during cardiac and thoracic interventions
US8097926B2 (en) * 2008-10-07 2012-01-17 Mc10, Inc. Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy
US8956346B2 (en) * 2010-05-14 2015-02-17 Rainbow Medical, Ltd. Reflectance-facilitated ultrasound treatment and monitoring
US8790300B2 (en) * 2010-12-06 2014-07-29 Boston Scientific Scimed, Inc. Dual balloon catheter
JP2013132364A (en) 2011-12-26 2013-07-08 Nippon Erekuteru:Kk Balloon catheter

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090182317A1 (en) * 2008-01-11 2009-07-16 Bencini Robert F Ablation devices and methods of use

Also Published As

Publication number Publication date
ES2793936T3 (en) 2020-11-17
IL245779A0 (en) 2016-07-31
JP2017192740A (en) 2017-10-26
IL262253A (en) 2018-11-29
WO2015081019A3 (en) 2015-10-22
US20160338752A1 (en) 2016-11-24
EP3073931B1 (en) 2020-05-13
CA2931484C (en) 2019-10-29
WO2015081019A2 (en) 2015-06-04
EP3073931A4 (en) 2017-10-11
JP6526106B2 (en) 2019-06-05
KR20160091971A (en) 2016-08-03
US10166058B2 (en) 2019-01-01
AU2014354940A1 (en) 2016-06-09
JP2017500928A (en) 2017-01-12
IL262253B (en) 2020-07-30
CA2931484A1 (en) 2015-06-04
JP6154073B2 (en) 2017-06-28
KR101827290B1 (en) 2018-03-22
CN105813576A (en) 2016-07-27
EP3073931A2 (en) 2016-10-05
IL245779B (en) 2018-10-31
AU2014354940B2 (en) 2016-12-22
CN105813576B (en) 2019-11-12

Similar Documents

Publication Publication Date Title
US20190133667A1 (en) Action/Counteraction Superimposed Double Chamber Board Area Tissue Ablation Device
US8579889B2 (en) Linear ablation devices and methods of use
US9636172B2 (en) Compliant balloon with liquid injection
US9603674B2 (en) Method to protect the esophagus and other mediastinal structures during cardiac and thoracic interventions
US20040220560A1 (en) Endocardial dispersive electrode for use with a monopolar RF ablation pen
US20060009756A1 (en) Method and devices for treating atrial fibrillation by mass ablation
KR20080110986A (en) System and methods for treating atrial fibrillation using electroporation
WO2013013098A1 (en) System and method for creation of cox maze lesions
US20220133400A1 (en) Ablation devices and methods of use
Raman et al. Combined endocardial and epicardial radiofrequency ablation of right and left atria in the treatment of atrial fibrillation
JP6570813B2 (en) Adaptive electrodes for bipolar ablation
US20190159835A1 (en) Cryopad
US20150051595A1 (en) Devices and methods for denervation of the nerves surrounding the pulmonary veins for treatment of atrial fibrillation
Bessière et al. Catheter Cryoablation: Biophysics and Clinical Applications
Biase et al. Catheter cryoablation for the treatment of ventricular arrhythmias

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

AS Assignment

Owner name: CORFIGO, INC., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SPERLING, JASON;REEL/FRAME:049504/0709

Effective date: 20190215

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION